eFFECTOR Therapeutics, Inc.
EFTRDelisted Jul 19, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001828522
eFFECTOR Therapeutics, Inc. was delisted on Jul 19, 2024; its insiders filed their last Form 4 on Jun 13, 2024; 18 institutions reported holding it in 13F filings for Q2 2024, worth $251.1K in total; no superinvestor held it.
Q3 2024 vs. Q2 2024
How the institutions holding eFFECTOR Therapeutics, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Q3 2024 | Change |
|---|---|---|---|
| Holders | 18 | 3 | −15 |
| Shares | 868.0K | 114.2K | −753.8K (−86.8%) |
| Value | $251.1K | $4.33K | −$246.8K (−98.3%) |
New holders (0)
Institutions that held eFFECTOR Therapeutics, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
None.
Sold out (15)
Institutions that held eFFECTOR Therapeutics, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Carlyle Group Inc. | 192,884 | $55.9K |
| Parallel Advisors, LLC | 67,738 | $19.7K |
| UBS Group AG | 61,667 | $17.9K |
| Geode Capital Management, LLC | 25,583 | $7.42K |
| Vanguard Group Inc | 25,070 | $7.27K |
| HRT Financial LP | 21,528 | $6.00K |
| Jane Street Group, LLC | 18,669 | $5.42K |
| Virtu Financial LLC | 18,021 | $5.00K |
| Two Sigma Investments, LP | 11,115 | $3.22K |
| Sea Otter Advisors LLC | 10,557 | $3.06K |
| Tower Research Capital LLC (TRC) | 9,805 | $2.84K |
| Morgan Stanley | 240 | $70 |
| Bank of America Corp | 31 | $9 |
| Qube Research & Technologies Ltd | 3 | $1 |
| Royal Bank of Canada | 546 | $0 |